Clinical impact of galectin-3 in newly diagnosed t (15;17)(q22;q21)/PML-RARa acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide-based regimens
- 292 Downloads
Increased galectin-3 expression has been currently showed to be associated with poor prognosis in some hematological malignancies, such as acute myeloid leukemia, diffuse large B cell lymphoma. However, little is known about the clinical significance of galectin-3 in patients with acute promyelocytic leukemia (APL). We investigated the concentration of serum galectin-3 and characterized the relationship between galectin-3 and outcome in patients with APL. Higher galectin-3 levels were detected in patients with APL compared with the healthy controls (p < 0.001). Higher galectin-3 levels were closely associated with older ages (p < 0.001), the medical history of psoriasis (p = 0.036), coagulopathy (p = 0.042), and CD34 expression (p = 0.004). Compared with patients with lower galectin-3 levels, those with higher galectin-3 levels had significant shorter overall survival (p = 0.028) and relapse-free survival (p = 0.001). Multivariate analysis showed that serum galectin-3 was an independent unfavorable factor for relapse-free survival in patients with APL treated with all-trans retinoic acid and arsenic trioxide-based frontline therapy. Clinical impact of galectin-3 should be further investigated in patients with APL.
KeywordsAcute promyelocytic leukemia Galectin-3 Prognosis Relapse Overall survival
This work was supported by the Medical and Health science and Technology Development Program (2015WS0508) of Shandong and Binzhou Medical University Scientific Research Fund (BY2013KJ38).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 3.Xu F, Yin CX, Wang CL et al (2014) Immunophenotypes and immune markers associated with acute promyelocytic leukemia prognosis. Dis Mark 2014:421906Google Scholar
- 4.Lucena-Araujo AR, Kim HT, Jacomo RH et al (2014) Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study. Ann Hematol 93:2001–2010CrossRefPubMedGoogle Scholar
- 18.Clark MC, Pang M, Hsu DK et al (2008) Increased serum 90 K and galectin-3 expression are associated with advanced stage and a worse prognosis indiffuse large B-cell lymphomas. Acta Haematol 120:211–216Google Scholar
- 21.Gabert J, Beillard E, van der Velden VHJ et al (2003) Standardization and quality control studies of real-time quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia: a Europe against cancer program. Leukemia 17:2318–2357CrossRefPubMedGoogle Scholar